Clinical study of efficacy of probing as a treatment for epiphora in adults

Kavitha, CV; Manipur, Sahana Raviraj; Acharya, Pavana; Lakshmi, B. Sowbagya

doi:10.4103/jcor.jcor_75_16

Cited by 3 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…8 Tsai et al reported patency rate of 94% 9 months after lacrimal probing with adjunctive mitomycin C for adults with blocked nasolacrimal ducts. 9 In a study conducted by Kavitha, et al 10 , probing was successful in 72.72% of their cases with epiphora . In our study, the symptomatic improvement rate was 66% with the first probing and 26 % with second probing.…”

Section: Discussionmentioning

confidence: 96%

An observational study on nasolacrimal duct probing in catarrhal stage of chronic dacrocystitis in Indian population

Tasneem¹,

Nayak²,

Rao³

et al. 2020

IJOOO

View full text Add to dashboard Cite

To estimate the efficacy of probing as a treatment option in earliest cases(early catarrhal stage) of epiphora with no discharge due to nasolacrimal duct obstruction. Materials and Methods: An observational clinical study was performed on 25 patients with earliest cases of epiphora with no discharge. Under aseptic precautions along with adequate topical and nasal anaesthesia probing was performed in both upper and lower canaliculi, it was considered successful when epiphora was reduced to a considerable level or had resolved with patent lacrimal system for atleast 6 months after syringing. Results: 14 women and 11 men with age group of 18 to 45 years with complains of epiphora for about 1 year were included in our study. 23 patients had nasolacrimal duct obstruction (NLDO) and 2 patients were post dacrocystorhinostomy (DCR).Complete patency was attained in 23 cases and 2 cases required surgical intervention. Treatment was successful in 92% cases. Conclusion: Probing is simple, safe, cost effective, patient satisfactory, quick and easy day care procedure with low intra and post procedural morbidity. Probing can avoid need of nasolacrimal surgeries and hence can be used as a treatment modality in earliest cases of epiphora with no discharge.

show abstract

Section: Discussionmentioning

confidence: 96%

An observational study on nasolacrimal duct probing in catarrhal stage of chronic dacrocystitis in Indian population

Tasneem¹,

Nayak²,

Rao³

et al. 2020

IJOOO

View full text Add to dashboard Cite

show abstract

Therapeutic Effects and Limitations of Lacrimal Endoscopy without Silicone Tube Intubation

Yoon¹,

Son²,

Ahn³

2023

J Korean Ophthalmol Soc

View full text Add to dashboard Cite

Purpose: To evaluate the effects and limitations of lacrimal endoscopy without silicone tube intubation in patients with epiphora.Methods: We conducted a retrospective chart review of 64 eyes in 49 patients who underwent lacrimal endoscopy between May 2021 and May 2022. The clinical characteristics, irrigation test results, lacrimal endoscopic findings, and type of surgery were analyzed.Results: The mean duration of symptoms was 31.2 months, and was significantly longer in the failure group than in the success group (<i>p</i> = 0.043). Irrigation tests showed passage, partial obstruction, and complete obstruction in 20 (31.3%), 16 (25.0%), and 28 (43.7%) eyes, respectively. Lacrimal endoscopy showed narrowing, mucus, fibrosis, granulation, and stones in 41 (64.0%), 12 (18.8%), 6 (9.3%), 3 (4.7%), and 2 (3.1%) eyes, respectively. Following lacrimal endoscopy, 32 (50.0%) eyes each were included in the success and failure groups. Preoperative irrigation test results did not affect the success rate (<i>p</i> = 0.203). Silicone tube intubation and dacryocystorhinostomy were performed in 5 (7.8%) and 8 (12.5%) eyes, respectively, because the symptoms did not improve after lacrimal endoscopy.Conclusions: Lacrimal endoscopy, performed without silicone tube intubation, was effective in improving symptoms and may guide the choice of surgical technique, if required.

show abstract

Evaluation of lacrimal duct probing in adults with 0.02% and 0.04% mitomycin-C in primary acquired nasolacrimal duct obstruction

Saini

Bajaj

Pushker

et al. 2022

Oman Journal of Ophthalmology

View full text Add to dashboard Cite

PURPOSE: The purpose of the study is to evaluate the safety and efficacy of adjunctive use of mitomycin-C (MMC) using two different concentrations 0.2 mg/ml and 0.4 mg/ml for lacrimal duct probing to treat the nasolacrimal duct obstruction (NLDO) in adults. SUBJECTS AND METHODS: Prospective, an interventional comparative randomized pilot study of lacrimal duct probing conducted in the two study groups 0.02% MMC group (n = 30) and 0.04% MMC group (n = 30) in confirmed primary acquired NLDO of <1-year duration. Patency of lacrimal duct probing confirmed by syringing was compared at 1, 3, and 6-month follow-up in the two study groups, and corresponding subjective improvement of watering was appraised according to Kraft and Crawford grading. RESULTS: Patency of lacrimal duct probing in 0.02% MMC versus 0.04% MMC group was 66.66%/73.33% (P = 0.71) at 1 month, 46.66%/66.66% (P = 0.09) at 3 months and 46.66%/66.66% (P = 0.03) at 6-month follow-up, respectively. Subjective improvement of watering (no watering and mild watering) observed in 0.02% MMC versus 0.04% MMC group was 46.66%/73.33% (P = 0.03), at 1 month, 66.66%/83.33% (P = 0.13) at 3 months and 56.66%/73.33% (P = 0.17) at 6-month follow-up. CONCLUSION: Adult lacrimal duct probing with 0.04% MMC was associated with significant higher objective success rate than adult lacrimal duct probing with 0.02% MMC, without added concurrently side effects.

show abstract

Clinical study of efficacy of probing as a treatment for epiphora in adults

Cited by 3 publications

References 0 publications

An observational study on nasolacrimal duct probing in catarrhal stage of chronic dacrocystitis in Indian population

An observational study on nasolacrimal duct probing in catarrhal stage of chronic dacrocystitis in Indian population

Therapeutic Effects and Limitations of Lacrimal Endoscopy without Silicone Tube Intubation

Evaluation of lacrimal duct probing in adults with 0.02% and 0.04% mitomycin-C in primary acquired nasolacrimal duct obstruction

Contact Info

Product

Resources

About